Bionano Genomics, Inc. Increase (Decrease) in Inventories
Bionano Genomics, Inc. (BNGO) reported Increase (Decrease) in Inventories of $29.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-10
- Bionano Genomics, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$77.00K.
- Bionano Genomics, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $106.00K.
- Bionano Genomics, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$1.57M.
- Bionano Genomics, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.51M, a 161.60% decline year-over-year.
- Bionano Genomics, Inc. increase (decrease) in inventories for fiscal 2025 was -$4.92M, a 937.48% decline from fiscal 2024.
- Bionano Genomics, Inc. increase (decrease) in inventories for fiscal 2024 was $587.00K, a 85.86% decline from fiscal 2023.
- Bionano Genomics, Inc. increase (decrease) in inventories for fiscal 2023 was $4.15M, a 82.47% decline from fiscal 2022.
- Bionano Genomics, Inc. increase (decrease) in inventories for fiscal 2022 was $23.68M, a 48.64% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $29.00K 10-Q · filed 2026-08-10 | -$1.54M derived: sum of 3 quarters · filed 2026-08-10 | -$3.05M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $106.00K 10-Q · filed 2026-05-13 | -$1.47M derived: sum of 2 quarters · filed 2026-05-13 | -$2.98M derived: sum of 3 quarters · filed 2026-05-13 | -$3.70M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$3.08M derived: sum of 2 quarters · filed 2026-03-23 | -$3.81M derived: sum of 3 quarters · filed 2026-08-10 | -$4.92M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.23M derived: sum of 2 quarters · filed 2026-08-10 | -$3.34M 10-Q · filed 2025-11-13 | -$6.28M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$724.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.83M 10-Q · filed 2026-08-10 | -$4.77M derived: sum of 3 quarters · filed 2026-08-10 | -$2.32M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$1.11M 10-Q · filed 2026-05-13 | -$4.04M derived: sum of 2 quarters · filed 2026-05-13 | -$1.60M derived: sum of 3 quarters · filed 2026-05-13 | -$723.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$486.00K derived: sum of 2 quarters · filed 2026-03-23 | $387.00K derived: sum of 3 quarters · filed 2026-03-23 | $587.00K 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.32M derived: sum of 2 quarters · filed 2025-11-13 | $3.52M 10-Q · filed 2025-11-13 | $3.85M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $873.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.07M 10-Q · filed 2025-08-14 | $1.40M derived: sum of 3 quarters · filed 2025-08-14 | -$2.12M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-14 | $531.00K derived: sum of 2 quarters · filed 2025-05-14 | -$3.00M derived: sum of 3 quarters · filed 2025-05-14 | -$1.36M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.19M derived: sum of 2 quarters · filed 2025-03-31 | -$1.56M derived: sum of 3 quarters · filed 2025-03-31 | $4.15M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.89M derived: sum of 2 quarters · filed 2024-11-14 | $3.82M 10-Q · filed 2024-11-14 | $9.37M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $7.34M 10-Q · filed 2024-08-07 | $12.90M derived: sum of 3 quarters · filed 2024-08-07 | $18.93M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $5.71M 10-Q · filed 2024-05-08 | $11.26M derived: sum of 2 quarters · filed 2024-05-08 | $17.29M derived: sum of 3 quarters · filed 2024-05-08 | $23.45M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $11.58M derived: sum of 2 quarters · filed 2024-03-05 | $17.74M derived: sum of 3 quarters · filed 2024-03-05 | $23.68M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $6.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $12.18M derived: sum of 2 quarters · filed 2023-11-08 | $18.12M 10-Q · filed 2023-11-08 | $23.70M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $6.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $12.10M 10-Q · filed 2023-08-09 | $17.68M derived: sum of 3 quarters · filed 2023-08-09 | $24.42M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $5.94M 10-Q · filed 2023-05-09 | $11.52M derived: sum of 2 quarters · filed 2023-05-09 | $18.26M derived: sum of 3 quarters · filed 2023-05-09 | $20.91M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $12.32M derived: sum of 2 quarters · filed 2023-03-09 | $14.97M derived: sum of 3 quarters · filed 2023-03-09 | $15.93M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $6.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $9.38M derived: sum of 2 quarters · filed 2022-11-03 | $10.35M 10-Q · filed 2022-11-03 | $10.94M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.60M 10-Q · filed 2022-08-04 | $4.19M derived: sum of 3 quarters · filed 2022-08-04 | $6.77M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $961.00K 10-Q · filed 2022-05-05 | $1.55M derived: sum of 2 quarters · filed 2022-05-05 | $4.13M derived: sum of 3 quarters · filed 2022-05-05 | $4.53M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.16M derived: sum of 2 quarters · filed 2022-03-01 | $3.57M derived: sum of 3 quarters · filed 2022-03-01 | $4.20M 10-K · filed 2022-03-01 | $4.20M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.98M derived: sum of 2 quarters · filed 2021-11-04 | $3.61M 10-Q · filed 2021-11-04 | $5.37M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $402.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.04M 10-Q · filed 2021-08-04 | $2.79M derived: sum of 3 quarters · filed 2021-08-04 | $2.72M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | $635.00K 10-Q · filed 2021-05-13 | $2.39M derived: sum of 2 quarters · filed 2021-05-13 | $2.32M derived: sum of 3 quarters · filed 2021-05-13 | $3.94M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $1.69M derived: sum of 2 quarters · filed 2021-03-23 | $3.30M derived: sum of 3 quarters · filed 2021-03-23 | $3.64M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.55M derived: sum of 2 quarters · filed 2020-11-13 | $1.89M 10-Q · filed 2020-11-13 | $1.89M 10-Q · filed 2019-11-07 | $203.53K derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $1.95M 10-Q · filed 2020-08-13 | $1.95M 10-Q · filed 2019-08-08 | $271.53K derived: sum of 3 quarters · filed 2020-08-13 | $2.20M derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $337.00K 10-Q · filed 2020-06-18 | $337.27K 10-Q · filed 2019-05-09 | -$1.35M derived: sum of 2 quarters · filed 2020-06-18 | $583.41K derived: sum of 3 quarters · filed 2020-06-18 | $435.63K derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $246.41K derived: sum of 2 quarters · filed 2020-03-10 | $98.63K derived: sum of 3 quarters · filed 2020-03-10 | $418.98K 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.78M derived: sum of 2 quarters · filed 2019-11-07 | $2.10M 10-Q · filed 2019-11-07 | $1.99M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$147.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $172.58K 10-Q · filed 2019-08-08 | $65.78K derived: sum of 3 quarters · filed 2019-08-08 | |||||
| 2018-03-31 | $320.36K 10-Q · filed 2019-05-09 | $213.56K derived: sum of 2 quarters · filed 2019-05-09 | ||||||
| 2017-12-31 | -$106.80K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $336.05K 10-K · filed 2019-03-14 | ||||||
| 2017-09-30 | $442.85K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |